The Private Sector and HIV/AIDS in Africa: Taking Stock of Six Years of Applied Research
Rosen, S. Feeley, R. Connelly P., et al. (2006).
This report summarizes the findings of private workplace studies conducted in South Africa, Uganda, Kenya, Zambia, Ethiopia, and Rwanda. The authors looked at direct costs to employers (medical expenses, the recruitment and training of replacement workers) as well as indirect costs (absenteeism, reduced productivity). The financial impact of HIV on employers was driven by HIV prevalence in the workforce, the job level of those affected, affected employees' terms of employment, and industrial sector. Treatment of eligible employees with antiretroviral therapy at a cost of US$360 per patient per year had positive financial returns for most but not all companies.